Cancer vaccine MUC-1 (Prima BioMed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCancer vaccine MUC-1 (Prima BioMed)

Drug Alias NameM-FP cancer vaccine癌症疫苗MUC-1Mannan-MUC1 fusion proteinMUC1 dendritic cell vaccineCVac

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulantsMucin-1 inhibitorsNatural killer cells stimulants

TargetsMucin-1

Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesImmutep Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmutep Ltd

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A